Critical Path Analysis Sample Clauses

Critical Path Analysis. During the period Provider is providing Transition Services, Provider shall maintain a “critical path analysis” for the particular Transition project that will indicate the impact on the Transition project time schedule and Transition milestones based upon any occurrences of acts, omissions or breaches by Provider, Xxxxxxx or third parties. Provider’s critical path analysis shall be provided to and reviewed with Xxxxxxx SOW Manager on at least a weekly basis and shall be presented to the Transition Management Committee (or if there is no Transition Management Committee, then the Steering Committee) or Xxxxxxx representative at each meeting during the particular Transition.
AutoNDA by SimpleDocs
Critical Path Analysis. Contractor shall provide with each Time Extension Request a quantitative demonstration of the impact of the delay on completion of the Work and Contract Time, based on the Work Progress Schedule. Contractor shall include with Time Extension Requests a reasonably detailed narrative setting forth: 12.11.3.1 The nature of the delay and its cause due to a change in the Work or an Excusable Delay and the basis of Contractor’s claim of entitlement to an extension of Contract Time. 12.11.3.2 Documentation of the actual impacts of the claimed delay on the critical path in Contractor’s Work Progress Schedule, and any concurrent delays. 12.11.3.3 Description and documentation of steps taken by Contractor to mitigate the effect of the claimed delay, including, when appropriate, the modification of the Work Progress Schedule.
Critical Path Analysis. ‌ To understand where and when key quality reviews need to take place, a critical path analysis has been undertaken to identify the major dependencies between WPs. This analysis shows the following key milestones [GA – Annex I Part A – 1.3.4. WT4 List of milestones]: MS1 Project startup WP1, WP2, LIUC 6 This milestone will be WP3, WP4, verified in terms of WP8 Project coordination setup (WP1); knowledge framework completed (WP2); background knowledge for analysis acquired (WP3 and WP4); basic dissemination infrastructure setup (WP8) MS2 Knowledge WP2, WP3, LIUC 15 This milestone will be framework WP4, WP8 verified in terms of first revision revision of knowledge framework completed (WP2); analytical research setup completed (WP3 and WP4); dissemination infrastructure fully operative (WP8) MS3 Analytical research completed WP3, WP4, WP5, WP6, WP7 LIUC 24 This milestone will be verified in terms of analytical research completed (WP3 and 4); exploratory research fully operative (WP5 and 6); integrative modelling fully operative (WP7) MS4 Final knowledge framework release WP2, WP3, WP4, WP8 LIUC 30 This milestone will be verified in terms of final revision of knowledge framework completed (WP2); analytical research setup completed (WP3 and WP4); dissemination infrastructure fully operative (WP8)
Critical Path Analysis. Analysis of the critical path throughout the project evolution reveals the following workpackage’s (Inputs/Outputs) that require particular attention (see Xxxxx Chart). The critical path in time for the EUDEM2 project starts with wokpackage WP200- Requirements & Concepts and the Concept Meeting with the Advisory Panel, in which the project direction and scope will be refined. Task WP330 Information Retrieval Facility is critical by itself. The realization of this task depends on the available information, and the implementation difficulties (interface/software) which are due to the different sources of information (data bases, web sites, etc …) and their coherence/completeness. A GO/ NO GO (M4) review is planned for this task at Month 10. WP400 Technology Survey is critical and depends on the inputs from WP600 Interviews as well as the available scientific/technology information. This is the reason for splitting it into several tasks.
Critical Path Analysis. As specified in D1.3, section 2.3 Critical Path Analysis, four milestones were set to be achieved by the end of the Project: MS1 Project startup WP1, WP2, WP3, WP4, WP8 LIUC 6 This milestone will be verified in terms of Project coordination setup (WP1); knowledge framework completed (WP2); background knowledge for analysis acquired (WP3 and WP4); basic dissemination infrastructure setup (WP8) MS2 Knowledge framework revision WP2, WP3, WP4, WP8 LIUC 15 This milestone will be verified in terms of first revision of knowledge framework completed (WP2); analytical research setup completed (WP3 and WP4); dissemination infrastructure fully operative (WP8) MS3 Analytical research completed WP3, WP4, WP5, WP6, WP7 LIUC 24 This milestone will be verified in terms of analyt- ical research completed (WP3 and 4); exploratory research fully operative (WP5 and 6); integrative modelling fully operative (WP7) MS4 Final knowledge framework release WP2, WP3, WP4, WP8 LIUC 30 This milestone will be verified in terms of final revision of knowledge framework completed (WP2); analytical research setup completed (WP3 and WP4); dissemination infrastructure fully op- erative (WP8) The following decisions of the SB meetings are related to the achievement of these Milestones: • Decision 9. Milestone MS1 has been achieved. • Decision 16. The achievement of the second milestone, MS2, will be decided in an online meeting of the SB, to be held by the end of March 2016. • Decision 19. Milestone MS2 has been achieved. • Decision 34. Milestone MS3 has been achieved. • Decision 38. Milestone MS4 has been achieved.

Related to Critical Path Analysis

  • Risk Analysis The Custodian will provide the Fund with a Risk Analysis with respect to Securities Depositories operating in the countries listed in Appendix B. If the Custodian is unable to provide a Risk Analysis with respect to a particular Securities Depository, it will notify the Fund. If a new Securities Depository commences operation in one of the Appendix B countries, the Custodian will provide the Fund with a Risk Analysis in a reasonably practicable time after such Securities Depository becomes operational. If a new country is added to Appendix B, the Custodian will provide the Fund with a Risk Analysis with respect to each Securities Depository in that country within a reasonably practicable time after the addition of the country to Appendix B.

  • Escrow Analysis If applicable, with respect to each Mortgage Loan, the Seller has within the last twelve months (unless such Mortgage was originated within such twelve month period) analyzed the required Escrow Payments for each Mortgage and adjusted the amount of such payments so that, assuming all required payments are timely made, any deficiency will be eliminated on or before the first anniversary of such analysis, or any overage will be refunded to the Mortgagor, in accordance with RESPA and any other applicable law;

  • Quantitative Analysis Quantitative analysts develop and apply financial models designed to enable equity portfolio managers and fundamental analysts to screen potential and current investments, assess relative risk and enhance performance relative to benchmarks and peers. To the extent that such services are to be provided with respect to any Account which is a registered investment company, Categories 3, 4 and 5 above shall be treated as “investment advisory services” for purposes of Section 5(b) of the Agreement.”

  • Investment Analysis and Implementation In carrying out its obligations under Section 1 hereof, the Advisor shall: (a) supervise all aspects of the operations of the Funds; (b) obtain and evaluate pertinent information about significant developments and economic, statistical and financial data, domestic, foreign or otherwise, whether affecting the economy generally or the Funds, and whether concerning the individual issuers whose securities are included in the assets of the Funds or the activities in which such issuers engage, or with respect to securities which the Advisor considers desirable for inclusion in the Funds' assets; (c) determine which issuers and securities shall be represented in the Funds' investment portfolios and regularly report thereon to the Board of Trustees; (d) formulate and implement continuing programs for the purchases and sales of the securities of such issuers and regularly report thereon to the Board of Trustees; and (e) take, on behalf of the Trust and the Funds, all actions which appear to the Trust and the Funds necessary to carry into effect such purchase and sale programs and supervisory functions as aforesaid, including but not limited to the placing of orders for the purchase and sale of securities for the Funds.

  • Sampling and Analysis The Seller has sole responsibility for quality control of the coal and shall forward its “as loaded” quality to the Buyer as soon as possible. The sampling and analysis of the coal delivered hereunder shall be performed by Buyer and the results thereof shall be accepted and used for the quality and characteristics of the coal delivered under this Agreement. All analyses shall be made in Buyer’s laboratory at Buyer’s expense in accordance with ASTM standards where applicable, or using standards mutually acceptable to both parties. Samples for analyses shall be taken by any ASTM standards or standards mutually acceptable to both parties, and may be composited and shall be taken with a frequency and regularity sufficient to provide reasonably accurate representative samples of the deliveries made hereunder. Seller represents that it is familiar with Buyer’s sampling and analysis practices, and finds them to be acceptable. Buyer shall notify Seller in writing of any significant changes in Buyer’s sampling and analysis practices. Any such changes in Buyer’s sampling and analysis practices shall, except for ASTM or mutually agreeable changes in practices, provide for no less accuracy than the sampling and analysis practices existing at the time of the execution of this Agreement, unless the Parties otherwise mutually agree. (1) part shall be used for analysis by Buyer; one (l) part shall be used by Buyer as a check sample, if Buyer in its sole judgment determines it is necessary; one (1) part shall be retained by Buyer (LG&E) until the twenty-fifth (25th) of the month following the month of unloading (the “LG&E Disposal Date”) or Buyer (KU) until thirty (30) days after the sample is taken (the “KU Disposal Date”), the LG&E Disposal Date and the KU Disposal Date are collectively the “Disposal Date”), and shall be delivered to Seller for analysis if Seller so requests before the Disposal Date; and one part (“Referee Sample”) shall be retained by Buyer until the Disposal Date. Seller shall be given copies of all analyses made by Buyer by the tenth (10th) business day of the month following the month of unloading. Seller, on reasonable notice to Buyer shall have the right to have a representative present to observe the sampling and analyses performed by Buyer. Unless Seller requests a Referee Sample analysis before the Disposal Date, Buyer’s analysis shall be used to determine the quality of the coal delivered hereunder. The Monthly Weighted Averages shall be determined by utilizing the individual shipment analyses. If any dispute arises before the Disposal Date, the Referee Sample retained by Buyer shall be submitted for analysis to an independent commercial testing laboratory (“Independent Lab”) mutually chosen by Buyer and Seller. For each coal quality specification in question, a dispute shall be deemed not to exist and Buyer’s analysis shall prevail and the analysis of the Independent Lab shall be disregarded if the analysis of the Independent Lab differs from the analysis of Buyer by an amount equal to or less than: (i) 0.50% moisture (ii) 0.50% ash on a dry basis (iii) 100 Btu/lb. on a dry basis (iv) 0.10% sulfur on a dry basis. For each coal quality specification in question, if the analysis of the Independent Lab differs from the analysis of Buyer by an amount more than the amounts listed above, then the analysis of the Independent Lab shall prevail and Buyer’s analysis shall be disregarded. The cost of the analysis made by the Independent Lab shall be borne by Seller to the extent that Buyer’s analysis prevails and by Buyer to the extent that the analysis of the Independent Lab prevails.

  • Research Analyst Independence The Company acknowledges that the Underwriters’ research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters’ research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters’ investment banking divisions. The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.

  • Independent Analysis Each Party hereby confirms that its decision to execute this Agreement has been based upon its independent assessment of documents and information available to it, as it has deemed appropriate.

  • Statistical Sampling Documentation a. A copy of the printout of the random numbers generated by the “Random Numbers” function of the statistical sampling software used by the IRO.‌ b. A description or identification of the statistical sampling software package used by the IRO.‌

  • Technology Research Analyst Job# 1810 General Characteristics

  • SERVICE MONITORING, ANALYSES AND ORACLE SOFTWARE 11.1 We continuously monitor the Services to facilitate Oracle’s operation of the Services; to help resolve Your service requests; to detect and address threats to the functionality, security, integrity, and availability of the Services as well as any content, data, or applications in the Services; and to detect and address illegal acts or violations of the Acceptable Use Policy. Oracle monitoring tools do not collect or store any of Your Content residing in the Services, except as needed for such purposes. Oracle does not monitor, and does not address issues with, non-Oracle software provided by You or any of Your Users that is stored in, or run on or through, the Services. Information collected by Oracle monitoring tools (excluding Your Content) may also be used to assist in managing Oracle’s product and service portfolio, to help Oracle address deficiencies in its product and service offerings, and for license management purposes. 11.2 We may (i) compile statistical and other information related to the performance, operation and use of the Services, and (ii) use data from the Services in aggregated form for security and operations management, to create statistical analyses, and for research and development purposes (clauses i and ii are collectively referred to as “Service Analyses”). We may make Service Analyses publicly available; however, Service Analyses will not incorporate Your Content, Personal Data or Confidential Information in a form that could serve to identify You or any individual. We retain all intellectual property rights in Service Analyses. 11.3 We may provide You with the ability to obtain certain Oracle Software (as defined below) for use with the Services. If we provide Oracle Software to You and do not specify separate terms for such software, then such Oracle Software is provided as part of the Services and You have the non-exclusive, worldwide, limited right to use such Oracle Software, subject to the terms of this Agreement and Your order (except for separately licensed elements of the Oracle Software, which separately licensed elements are governed by the applicable separate terms), solely to facilitate Your use of the Services. You may allow Your Users to use the Oracle Software for this purpose, and You are responsible for their compliance with the license terms. Your right to use any Oracle Software will terminate upon the earlier of our notice (by web posting or otherwise) or the end of the Services associated with the Oracle Software. Notwithstanding the foregoing, if Oracle Software is licensed to You under separate terms, then Your use of such software is governed by the separate terms. Your right to use any part of the Oracle Software that is licensed under the separate terms is not restricted in any way by this Agreement.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!